Guidelines – Page 4 – Policy & Medicine

Interim Final Rule Released on Surprise Billing and Out-of-Network Charges

HHS Releases Notice of Benefit and Payment Parameters for 2022, Part Two

Stark Law Final Rule Is Effective

FDA Releases Draft Guidance on IND Submissions for Individualized Antisense Oligonucleotide Drug Products

New Final Rule in Effect Updating AKS Safe Harbors

What Does the Consolidated Appropriations Act Mean to Industry?

Trump Administration Makes Final Proposed Rule Push

FDA Issues Draft Guidance on Proprietary Names

HHS ONC Releases Final Rule Implementing the Cures Act

FDA Releases Draft Guidance on Biosimilar Review